ALXO
ALXO
US00166B1052
ALX Oncology Holdings Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
172.85M EUR
286.11M EUR
269.75M EUR
61.46M EUR
Enterprise Value
35.98M EUR
273.13M EUR
245.98M EUR
54.83M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-2.32x
--
--
--
Price to Sales
--
--
--
--
Price to Book
1.27x
2.1x
1.78x
2.37x
EV/Revenue
--
--
--
--
EV/EBITDA
-0.44x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-23.81%
-24.8%
-29.04%
-97.03%
ende